cupure logo
trumpisraeldayiranparadeindiacrashairwatchfathers

‘Milestone’ treatment could reshape future leukaemia care

‘Milestone’ treatment could reshape future leukaemia care
The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression after five years

Comments

Similar News

Breaking news